Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eimeria brunetti is a species of apicomplexan protozoa that causes coccidiosis in poultry, primarily affecting the lower small intestine, rectum, and ceca (Merck Veterinary Manual). It is characterized by its high pathogenicity, often resulting in hemorrhagic enteritis, mucoid discharge, and significant mortality in domestic chickens (ScienceDirect). The parasite's life cycle involves the destruction of host epithelial cells during schizogony and gametogony, which impairs nutrient absorption and gut integrity (PubMed). While E. brunetti is the biological entity targeted by various veterinary medicines, it is an entire organism rather than a specific molecular target like a receptor or enzyme. Pharmacological control relies on anticoccidial agents such as ionophores, which disrupt ion transport across parasite membranes, and synthetic chemicals that inhibit intracellular development (Journal of Parasitology). Management of E. brunetti is a critical component of poultry production due to the rapid development of drug resistance and the economic impact of subclinical infections.
Anticoccidial drugs target the parasite through various mechanisms: ionophores (e.g., monensin) form complexes with alkali metal cations to disrupt osmotic balance (Merck Veterinary Manual); amprolium acts as a thiamine antagonist (PubMed); and triazines (e.g., toltrazuril) interfere with nuclear division and mitochondrial activity (ScienceDirect).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eimeria brunetti (E. brunetti).